Gyrodyne, LLC
Market Movers (8-K)
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne's subsidiary GSD Flowerfield LLC amended its purchase agreement with B2K Smithtown LLC, providing a $1.52 million credit for on-site improvements and setting a new deadline for resolving land use covenants.
Delay expected
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne, LLC's 2025 annual meeting saw shareholders approve the election of a director, executive compensation on an advisory basis, and the ratification of its independent accounting firm.
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne, LLC provided an update on its property sales, ongoing litigation, and financial performance, revealing a decrease in estimated liquidating distributions per share despite an increase in total net asset value.
Delay expected
Worse than expected
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne, LLC has reached agreements with Star Equity Fund and Leap Tide Capital Management, resolving a proxy contest and implementing significant corporate governance changes including board reduction and director compensation limits.
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne, LLC announced the sale of a 49-acre parcel in St. James, New York, for $24M-$28.74M, projecting a significant increase in Net Asset Value per share.
Delay expected
Better than expected
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne, LLC secured a favorable ruling in the New York Supreme Court, dismissing a challenge to its Flowerfield property subdivision approval.
Quarterly Earnings (10-Q)
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne LLC reports a slight increase in net assets in liquidation for Q1 2026, with ongoing efforts to maximize property values and navigate legal challenges, while projecting liquidation completion by year-end 2028.
Delay expected
Capital raise
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne, LLC reports increased net assets and an extended liquidation timeline to 2027, driven by a new property sale agreement and ongoing entitlement efforts.
Delay expected
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne, LLC reports an increase in net assets and estimated per-share distributions, driven by real estate value gains and a new property sale agreement, despite ongoing legal challenges and an extended liquidation timeline.
Delay expected
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne, LLC's net assets in liquidation increased slightly to $30.81 million in Q1 2025, driven by increased rental revenue and cost savings, while the company continues to pursue entitlements and defend against legal challenges.
Delay expected
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne LLC's Q3 2024 report reveals a decrease in net asset value primarily due to a reduction in real estate value and increased liquidation costs, partially offset by proceeds from a rights offering.
Worse than expected
Delay expected
Capital raise
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne LLC's net assets in liquidation increased to $35.39 million as of June 30, 2024, primarily due to a successful rights offering.
Worse than expected
Delay expected
Capital raise
Annual Reports (10-K)
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne, LLC, a real estate company focused on property liquidation, has extended its estimated dissolution timeline to December 31, 2028, due to ongoing legal challenges and regulatory delays impacting its Flowerfield and Cortlandt Manor properties.
Delay expected
Worse than expected
Capital raise
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne LLC's 2024 10-K filing outlines its strategy to enhance property values through entitlement efforts, liquidate assets, and distribute proceeds to shareholders by 2026.
Worse than expected
Delay expected
NASDAQ
GYRO
Gyrodyne, LLC10-K: Gyrodyne LLC Navigates Entitlements and Liquidation Amidst Legal Challenges and Market Volatility
Gyrodyne LLC is focused on enhancing property values through entitlements and strategic sales, while managing legal challenges and macroeconomic uncertainties as it moves towards liquidation.
Worse than expected
Delay expected
Capital raise
Insider Trading (Form 4)
NASDAQ
GYRO
Gyrodyne, LLCTowerview LLC, a 10% owner of Gyrodyne, LLC, reported a planned future sale of 1,973 common shares at $12.55 per share under a Rule 10b5-1 plan.
NASDAQ
GYRO
Gyrodyne, LLCRonald J. Macklin, a Director and 10% owner of Gyrodyne, LLC, filed an amended Form 4 to correct the number of shares acquired and beneficially owned following a rights offering.
Capital raise
NASDAQ
GYRO
Gyrodyne, LLCTowerView LLC, a 10% owner and director of Gyrodyne, LLC, filed an amended Form 4 to correct the number of common shares sold on August 4, 2025.
NASDAQ
GYRO
Gyrodyne, LLCTowerView LLC, a 10% owner and director of Gyrodyne, LLC, reported the sale of 1,216 common shares at $12.10 per share.
Worse than expected
NASDAQ
GYRO
Gyrodyne, LLCTowerView LLC, a 10% owner of Gyrodyne, LLC, has sold a portion of its common shares in multiple transactions between October 18 and October 21, 2024.
NASDAQ
GYRO
Gyrodyne, LLCPaul Lamb, a director of Gyrodyne, LLC, filed an amendment to his Form 4 to correct the amount of securities indirectly held in his Individual Retirement Account (IRA).
Proxy Statements (Def-14A)
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne, LLC announces its 2025 Annual Meeting to elect a director, approve executive compensation, and ratify auditors, following a resolved proxy contest.
Worse than expected
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne, LLC is soliciting proxies for its upcoming annual meeting on October 7, 2024, to vote on the election of a director, an advisory vote on executive compensation, and the ratification of its independent auditor.
New Public Companies (S-1)
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne, LLC is offering non-transferable subscription rights to shareholders to purchase up to 625,000 common shares at $8.00 per share, aiming to raise $5 million to bolster its liquidation process and defend property rights.
Worse than expected
Delay expected
Capital raise
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne, LLC is offering non-transferable subscription rights to shareholders to purchase up to 625,000 common shares at $8.00 per share, aiming to raise $5 million for property entitlement efforts, legal defense, and working capital.
Capital raise
NASDAQ
GYRO
Gyrodyne, LLCGyrodyne, LLC is launching a rights offering to raise $5 million to support its liquidation strategy, including legal defenses and property entitlement pursuits.
Worse than expected
Delay expected
Capital raise
Schedule 13D - Activist Investments
NASDAQ
GYRO
Gyrodyne, LLCStar Equity Fund, LP and Gyrodyne, LLC have entered into a settlement agreement, leading to the withdrawal of Star Equity's director nominations and changes to Gyrodyne's board structure and governance.
NASDAQ
GYRO
Gyrodyne, LLCStar Equity Fund and its affiliates have increased their beneficial ownership in Gyrodyne, LLC to 7.1% and nominated two individuals for the company's board of directors.
NASDAQ
GYRO
Gyrodyne, LLCSCHEDULE 13D/A: Star Equity Fund Launches Proxy Contest for Gyrodyne Board Seats, Nominates Two Directors
Star Equity Fund, holding a 7.1% stake in Gyrodyne, LLC, has initiated a proxy solicitation to elect two new director nominees, Hannah M. Bible and Matthew R. Sullivan, to the company's board at the 2025 annual meeting.
Schedule 13G - Passive Investments
NASDAQ
GYRO
Gyrodyne, LLCSCHEDULE: Neil Subin Cuts Gyrodyne Stake Below 5%
Neil S. Subin has reduced his beneficial ownership in Gyrodyne, LLC to 4.9%, triggering an exit filing with the SEC.